Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60,026,563
-
Total 13F shares
-
31,692,851
-
Share change
-
+9,598,032
-
Total reported value
-
$376,513,639
-
Put/Call ratio
-
126%
-
Price per share
-
$11.88
-
Number of holders
-
107
-
Value change
-
+$122,609,589
-
Number of buys
-
61
-
Number of sells
-
43
Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q1 2021
As of 31 Mar 2021,
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) was held by
107 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,692,851 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, First Light Asset Management, LLC, Avidity Partners Management LP, STATE STREET CORP, VANGUARD GROUP INC, BlackRock Inc., TWO SIGMA INVESTMENTS, LP, TWO SIGMA ADVISERS, LP, FMR LLC, and Woodline Partners LP.
This page lists
107
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.